Climb Bio Inc (CLYM) — Financial Flexibility Index
Climb Bio Inc (CLYM) has a Financial Flexibility Index of -3.35x as of March 2026. Free cash flow of $-14.38 Million (operating CF $-14.38 Million minus capex $0.00) represents -3% of total liabilities ($4.29 Million). Also explore Climb Bio Inc (CLYM) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Climb Bio Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Climb Bio Inc across 7 annual periods. Check asset allocation strategy of Climb Bio Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Climb Bio Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Climb Bio Inc. For the full company profile including market capitalisation, see Climb Bio Inc (CLYM) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -7.45x | $-54.17 Million | $-54.36 Million | $7.27 Million | ▼ -154.1% |
| 2024 | -2.93x | $-15.56 Million | $-15.56 Million | $5.31 Million | ▲ +59.1% |
| 2023 | -7.18x | $-20.60 Million | $-20.60 Million | $2.87 Million | ▼ -20.6% |
| 2022 | -5.95x | $-37.37 Million | $-37.37 Million | $6.28 Million | ▲ +0.3% |
| 2021 | -5.97x | $-36.07 Million | $-36.07 Million | $6.04 Million | ▼ -29.8% |
| 2020 | -4.60x | $-14.10 Million | $-14.10 Million | $3.06 Million | ▲ +28.0% |
| 2019 | -6.40x | $-5.01 Million | $-5.01 Million | $783.00K | — |